Trial Profile
Serious Infections after Tocilizumab Administration in Patients with Rheumatoid Arthritis: A Retrospective Study Using an Adverse Drug Reaction Database -Analysis of Clinical Symptoms and Laboratory Test Data in Serious Infections-
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Jan 2017
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- Sponsors Chugai Pharmaceutical
- 28 Sep 2016 New trial record